The U.S. Army's missile stockpile is currently dwindling and could take years to replenish, raising concerns about long-term military readiness. Meanwhile, the Food and Drug Administration (FDA) is in the process of deciding whether to approve a flu vaccine that utilizes mRNA technology, a development that could impact future influenza prevention strategies.

These updates highlight ongoing challenges in both defense resources and public health innovation within the United States.

Sources